Rupak Pathak News Today

The study will focus on the relationship between chronic kidney disease, or CKD, and platelets, the small, colorless fragments in blood that form clots and stop or prevent bleeding.

The U.S. announced the purchase of nearly $300 million worth of the drug last week—heres how it works.

The five-year study aims to encourage drug development for therapies that will reduce the effects of such injuries.